Abstract Antibiotic resistant features of Acinetobacter baumannii is partly due to the decreased outer membrane proteins (OMPs) permeability.
vectors, respectively. The recombinant vectors containing ompA were then validated using colony PCR, vector sequencing and double-digestion strategies. The pBudCE4.1-ompA recombinant plasmid was transfected into the human dermal fibroblast cells (HDF) and presence of ompA transcript and protein was evaluated using reverse transcribed-PCR (RT-PCR) and sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Our finding from colony PCR, sequencing and enzyme double digestion result confirmed that target gene has been successfully inserted into the pTZ57RT and pBudCE4.1. The presence of an expected band (1112 bp) in RT-PCR as wells as a * 38 kDa band during SDS-PAGE showed that the recombinant pBudCE4.1-ompA construct was efficiently transfected into the HDF cells and expressed. Altogether, our observation demonstrated that the recombinant pBudCE4.1-ompA construct was successfully produced although further experiments are needed.
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Introduction
Acinetobacter baumanni is one the most cause of endemic and epidemic nosocomial infections including bacteremia, urinary tract infection, wound infections and meningitis [1] . The resistant feature of the bacteria to the broad spectrum of antibacterial agents such as penicillins, carbapenems, aminoglycosides and cephalosporins makes them untreatable and increase the pathogen-associated mortality rate unbelievably [2, 3] . In the last decade, the multidrug resist strains of A. baumannii are rapidly emergenced in a way that Infectious Diseases Society of America (IDSA) introduces the A. baumannii as one the most dangerous microbes [4] . Therefore, the need to develop an efficient vaccination system against this opportunistic human pathogen seems urgent [5] . Several molecular mechanisms seems to be involved in multidrug resistance (MDR) phenotype of A. baumannii among which decreased outer membrane protein (OMP) permeability, overexpression of efflux pumps are relatively well studied [6] [7] [8] . The OMPs are actually bacterial porins seems to be associated with multi drug resistant phenotype of acinetobacter species and act as cell surface channels to export the antibacterial agents outside the cell [9] . The outer membrane protein A (OmpA), is one the most abundant porins in gram negative bacteria which can regulate the cellular permeability and A. baumannii is no exception [10] . The OmpA attaches to eukaryotic cells, translocate into the nucleus and induce cell death [11] . It can also inactive the complement system's response by capturing the serum factor H [12] . These issues trigger the idea that OMPs can be considered as potent targets to fight Acinetobacter species. Regarding to above mentioned information, this study was aimed to develop a DNA vaccine construct in which ompA gene was considered as immunogenic inducer. It is necessary to mentioned that OmpA is one of the most conserved porins in A. baumannii genus which is actively involved in bacterial survival, virulence, cell adhesion, host invasion and immune evasion [9, 13] .
Materials and Methods

Bacterial Strains and Cell Lines
Acinetobacter baumanni ATCC 19606 and E. coli NovaBlue were obtained from the Iranian Biological Resource Center (IBRC) and Cellular and Molecular Research Center of Shahrekord, University of Medical Sciences, respectively. These strains were grown under optimal conditions in Luria-Bertani (LB) agar (Merck Co., Germany) containing 5 g l -1 sodium chloride, 5 g l -1 yeast extract, 10 g l -1 tryptone, typically combined with 15 g l -1 agar (Difco, USA) overnight at 37°C. Human dermal fibroblast cells (HDF) were purchased from the National Cell Bank of Iran, Pasteur Institute and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 100 lg ml -1 inactivated fetal calf serum (FCS) (Gibco, USA) and 100 U ml -1 penicillin, and 100 mg ml -1 streptomycin (Life Technologies). All cells were grown at 37°C in a humidified atmosphere of 5% CO 2 . The cells were trypsinized every 2 days using 0.25 mM Trypsine-EDTA (Gibco, USA).
Vectors and Plasmids
The pTZ57RT easy vector (Thermo Scientific, Lithuania) and pBudCE4.1 ( Fig. 1) (Invitrogen, USA) were used as cloning and expression vectors, respectively.
Extraction of Genomic DNA from Acinetobacter baumanni
Genomic DNA was isolated from bacterial colonies using DNA extraction kit (Qiagen DNA Mini Kit,) according to manufacturer's instruction. The quality and quantity of final extracted DNA were checked on 1% agarose gel electrophoresis stained with ethidium bromide and Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) at a wavelength of 230, 260 and 280 nm.
Polymerase Chain Reaction (PCR)
The ompA nucleotide sequence from A. baumannii (Accession number: AY485227) was recruited from National Center for Biotechnology Information (https://www.ncbi. nlm.nih.gov). Specific primers were designed using Gene Runner software version 3.5 to amplify a 1112 bp fragment from ompA gene, as given in Table 1 . Two restriction sites for XbaI and BamHI were included in forward and reverse primers, respectively. PCR reaction was performed in a total reaction volume of 25 ll containing 2.5 ll of 109 PCR buffer, 2 mM MgCl 2 , 100 mM dNTPs, 1 lM of each primer, 1 lg of DNA sample and 1 unit of Taq DNA polymerase (Fermentas, Germany). The final volume was adjusted with nuclease-free water. PCR temperature was optimized as initial denaturation at 95°C for 5 min, followed by 35 cycles; denaturation at 94°C for 1 min, annealing at 61°C for 1 min and extension at 72°C for 1 min. Ultimately, a final extension phase was programmed at 72°C for 10 min,. The PCR products were then evaluated on 2% agarose gel electrophoresis and visualized by ethidium bromide staining on UV transilluminator.
Construction of ompA-Containing Recombinant Plasmids
The amplified product was purified from the gel using AccuPrep Ò Gel Purification (Bioneer, Korea) according to the manufacturer guideline and cloned into the pTZ57R/T cloning vector (Thermo Scientific, Lithuania) following the manufacturer's instruction. The E. coli NovaBlue competent cells were generated based on the calcium chloride method [14] . The competent cells were then cultured in LB agar media containing Xgal (20 mg ml -1 ), IPTG (isopropyl-b-D-thiogalactoside) (0.1 M) and Ampicillin (100 lg ml -1 ) to screen the recombinant vectors at 37°C overnight. The white colonies were selected and were cultured again in LB broth media enriched with 100 lg ml -1 Ampicillin. The recombinant vector was purified using Plasmid Mini Extraction Kit (Bioneer, Korea) as described in its protocol. To confirm the accuracy of cloning, the recombinant vector was digested with XbaI and BamHI restriction enzymes as well as PCR analysis by means of ompA-specific primers.
Sub-cloning of ompA Gene into pBudCE4.1 Eukaryotic Expression Vector
To construct the pBudCE4.1-ompA (Fig. 1) , the pTZ57RT-ompA recombinant vector was double digested with XbaI and BamHI. The ompA was then purified using AccuPrep Ò Gel Purification (Bioneer, Korea) and gently mix with linearized pBudCE4.1 according to the instruction. T4 ligase enzyme was used to generate the pBudCE4.1-ompA recombinant construct. The E. coli NovaBlue competent cells were then transformed with pBudCE4.1-ompA and cultured in LB-Zeocine (25 lg ml -1 ) plates. Polymerase chain reaction and XbaI/ BamHI double digestion were applied to verify the pBudCE4.1-ompA construct.
Transfection of HDF Cells with pBudCE4.1-ompA Construct
Transfection assay was performed using Lipofectamine 2000 reagent (Invitrogen, USA) when the confluency of HDF cells reached to 80-85%. One day before transfection, the HDF cells trypsinized and were plated in 6-well plates (1 9 10 6 cells per well). Lipofectamin 2000 reagent and recombinant pBudCE4.1-ompA were diluted by Opti-MEM separately. Diluted vector was added to the diluted lipofectamin in 1:1 ratio and incubated for 5 min at room temperature. The lipid-DNA complex was then added to the HDF cells in a serum-free DMEM for 6 h. The media was then replaced with complete fresh media containing 50 lg ml -1 Zeocine as a selectable marker. The HDF cells transfected with pBudCE4.1 (without gene of interest) were also considered as control of transfection (Blank).
RNA Extraction
To reveal if the transfection worked, total RNA was extracted from HDF cells (1 9 10 5 cells) using RNXPlus reagent according to the manufacturer's protocol. The integrity of extracted RNA was checked on 2% agarose gel electrophoresis and the presence of 18sRNA (800 bp) and 28srRNA (1500 bp) was traced in extracted RNA samples. Additionally, the concentration and purity of the genomic DNAs were then evaluated by Nanodrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) reading at wave length 230, 260 and 280 nm. The RNA was considered pure if the absorbance ratio of 260/280 nm and 260/230 nm was around 2.
Complementary DNA (cDNA) Synthesis and RT-PCR
Complementary DNA (cDNA) was synthesized using a reaction containing 500 ng ll -1 RNA, 100 mM dNTPs, 10 ll 59 RT-PCR buffer, 200 mM oligdT primer and 1 U ll -1 M-MuLV reverse transcriptase, (Invitrogen, USA) in a total volume 20 ll. The mixture was incubated at 42°C for 1 h followed by enzyme inactivation; 15 min in 70°C. The ompA transcript was amplified using the specific primers as shown in Table 1 . The reaction was carried out in total volume of 20 ll containing 50 mM MgCl 2 , 0.25 mM of each dNTP, 2 pmol l -1 of each primer, 10 ng ll
cDNA templates and 1 U of Taq DNA polymerase (Fermentas, Germany). The final volume was adjusted with nuclease-free water. PCR was optimized in thermocycler and comprised of 5 min denaturation at 95°C for initial denaturation followed by 25 cycles of denaturation; 94°C for 1 min, annealing; 61°C for 1 min, extension; 72°C for 45 s, final extension; 72°C for 2 min. A sample without DNA template (negative control: NTC) was included in all PCR reactions as negative control. The PCR products were then analyzed on 1% agarose gel electrophoresis dyed with 2% ethidium bromide and product bands were visualized under ultraviolet light.
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS PAGE) Analysis
Following 48 h post-transfection, the cells were harvested and centrifuged at 6000 rpm for 20 min at 4°C. Cell pallet was ultrasonically broken (300 V, 5 s 9 3). The obtained cell lysate was electrophoresed on SDS-PAGE to detect the recombinant OmpA protein based on its molecular weight. A protein lysate from HDF cells transfected with empty pBudCE4.1 vector, was also considered as blank of SDS PAGE.
Results
The Recombinant Constructs-pTZ57RT-ompA and pBudCE4.1-ompA were Validated Using Polymerase Chain Reaction
As illustrated in Fig. 2 , the presence of 1112 bp band shows that the ompA has been successfully cloned into the pTZ57RT vector. This also validated using double digestion with XbaI and BamHI restriction enzymes. The presence of 2886 and 1112 bp bands was associated with pTZ57RT and ompA amplicon respectively (Fig. 3) . Similarly, the result of colony PCR and XbaI/BamHI double digestion demonstrated that ompA has been successfully subcloned in pBudCE4.1 expression vector (Fig. 4) . 
RT-PCR Demonstrated that HDF cells Received the pBudCE4.1-ompA
To confirm whether the pBudCE4.1-ompA has been successfully expressed in HDF cells, RT-PCR was performed on RNA extracted from transfected HDF cells using ompA specific primers. As indicated in Fig. 5 , the presence of 1112 bp band showed that the cells uptake and express the construct.
The Recombinant Construct pBudCE4.1-ompA
Efficiently Expressed OmpA Protein in HDF Cells
To reveal if the pBudCE4.1-ompA construct can express the OmpA protein, the HDF cells were transfected with recombinant vector for 48 h. The cell extract was then analyzed by SDS-PAGE to find the OmpA protein.
As illustrated in Fig. 6 , a 38 kDa band was observed on the PAGE which is similar to the predicted molecular weight of OmpA.
Discussion
This is the first experimental report to design a novel eukaryotic vector to clone the ompA gene from A. baumannii with a potential to be used as DNA vaccine. The OmpA was selected as immunogen, as the OmpA protein allocated the high degree of homology (* 99%) among the all Acinetobacter species [15] . Additionally, it has demonstrated that OmpA is associated with multidrug resistant phenotype in Acinetobacter species [7, 8] . Our study can be considered novel as all previously reported immunization strategies against Acinetobacter species was achieved using either inactivated bacteria or purified synthetic outer membrane protein and other competent [1, [16] [17] [18] [19] . On the other hand applying the eukaryotic vector to clone the ompA gene makes it promising construct to inject as the DNA vaccine in human. Such eukaryotic expression vectors produce permanent and long lasting immunity in the body [20, 21] . Besides, our selected vectors has two multiple cloning sites makes it suitable to be used as a multivalent (divalent) DNA vaccine. Generally, DNA vaccines are in interest due to their efficient and long lasting immunity [20] . They are easily manipulated and in spite of protein vaccines do not require specialized storage condition. Mass production of DNA vaccine can be easily achieved cost-effectively. It is also important to stress that DNA vaccines are considered safe and well tolerated as this generation of vaccine is not included with any weakened or dead pathogenic agents [20] [21] [22] . In fact, DNA vaccines are engineered plasmids carrying a desired gene to stimulate the specific immune response against a broad range of pathogens including bacteria, fungi or viruses [21] . The DNA vaccine has been also become attractive for scientists as many organisms are either non-culturable or cannot be attenuated as a vaccine. Besides, their ability to induce a variety of immune responses (both humeral and cellular), makes them as a powerful immunogenic tools [20] [21] [22] .
Among different genus of Acinetobacter species, only A. baumannii, A. nosocomialis and A. pittii are the most clinically important types [23] . In comparison to all genus of Acinetobacter, A. baumannii is connected with the highest degree of mortality, morbidity and antimicrobial All the samples were analyzed by SDS-PAGE, and the protein was stained with coomassie blue in the gel. Lane M: molecular mass marker in 10 kDa; Lane 1: whole cells lysate of the HDF with pBudCE4.1; Lane 2: the HDF including pBudCE4.1-ompA, 6 h after transfection; Lane 3-4, the whole cells lysate of the HDF contained recombinant pBud-CE4.1-ompA, after 48 h; Lane 5: blank control (color figure online) resistance [24] . There is probably the reason that explains why A. baumannii is the favorite Acinetobacter genus for researchers to develop DNA vaccine than the others genus. Until now, limited studies were performed on A. baumannii to develop efficient immunization protocols. Inactivated whole cells, outer membrane proteins (OMPs) [25, 26] , outer membrane vesicles (OMVs) [26] , surface autotransporter Ata [18] , biofilm-associated proteins [27] , K1 capsular polysaccharide [28] and surface polysaccharide poly-N-acetyl-b-(1-6)-glucosamine (PNAG) [29] of A. baumannii are some effectual approaches to develop the vaccination protocol until now.
In study by Moriel et al., 62 antigens were identified in all A. baumannii species that could be used as potential vaccine targets and ompA was presented as one of these candidates [30] . In 2012, Luo and coworkers showed that rOmpA protein can produce active and passive immunization following the injection into the diabetic mice suffering from A. baumannii infection although serum resistant was not achieved [31] . In another study by Lin et al., they showed that OmpA protein can protect the A. baumannii-induced infection in mice through the induction of IL-4 and INF-c signaling pathways [32] . Similarly, Alzubaidi et al. demonstrated that coinjection of OmpA protein with chitosan nanoparticle as adjuvant increased the humoral immunity and appraised the efficiency of the vaccination against A. baumannii in mice [33] .
Although no DNA vaccine has been constructed for A. baumannii until now, our study can be considered promising. However, it should not be ignored the oncogenic potential of such recombinant molecules following a random integration into the host genome. Additionally, the immunogenic properties will be increased if the vaccine is used with adjuvants like IL-4 or GMSF. These are the issues that should be addressed in future experiments.
Conclusion
In this study the ompA gene of A. baumannii was successfully cloned into the pBudCe4.1 eukaryotic expression vector. The capacity of vector to express OmpA protein was confirmed in HDF cells using RT-PCR. So we suggest pBudCE4.1-ompA construct as a DNA vaccine candidate against A. baumannii although further experiments are needed.
